Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_assertion type Assertion NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_head.
- NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_assertion description "[CCL5 functions as an adjuvant to boost anti-tumor immunity by diverse protocols such as co-immunization of recombinant CCL5 protein with tumor-associated antigen, vaccination with CCL-5-expressing tumor cells, or viral vector delivery of CCL5 cDNA into growing tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_provenance.
- NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_assertion evidence source_evidence_literature NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_provenance.
- NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_assertion SIO_000772 20233026 NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_provenance.
- NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_assertion wasDerivedFrom befree-2016 NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_provenance.
- NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_assertion wasGeneratedBy ECO_0000203 NP800211.RARwS9VN-ocL88jYu1-Eau1768Dgb4gYtSKRTdV0BbGeQ130_provenance.